{"schema_version":"secwatch.filing_event.v1","accession":"0001479681-24-000008","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.204476+00:00","generated_at":"2026-05-31T10:49:37.967356+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nutex Health Q2 revenue up 29% to $76.1M; Adjusted EBITDA up 200% to $12.0M","bullets":["Net loss attributable to Nutex of $0.4M vs $3.5M loss in Q2 2023; H1 net loss $0.7M vs $8.6M.","Hospital division visits 41,208 in Q2 (+28% YoY); mature hospital revenue +13.2%.","Adjusted EBITDA (attributable) $12.0M in Q2, up 200% YoY; H1 Adjusted EBITDA $16.6M (+159%).","Operating cash flow of $16.3M in H1 2024; cash $40.8M, long-term debt $22.4M.","Non-cash impairments of $3.5M assets and $3.2M goodwill; $3.1M gain on warrant liability."],"urls":{"canonical":"https://secwatch.observer/filing/0001479681-24-000008","json":"https://secwatch.observer/filing/0001479681-24-000008.json","markdown":"https://secwatch.observer/filing/0001479681-24-000008.md","text":"https://secwatch.observer/filing/0001479681-24-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000147968124000008/0001479681-24-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000147968124000008/nutx-20240808x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:49:37.967356+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}